"What does it mean if someone has to mortgage their house to self-fund a cancer treatment that is not reimbursed? Is that timely access at a cost the community can afford? Or, just timely access to a medicine a particular person can afford?" asked MSD's Nicola Richards.
MSD's Nicola Richards: We need to clearly define and measure timely access
October 18, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
This exchange on the HTA Review was about as underwhelming as it sounds
October 9, 2025 - - Latest News -
AusBiotech unveils international conference program for Australia’s biggest week in biotech
October 9, 2025 - - Australian Biotech -
Life sciences industry calls for stronger national strategy to support trials and innovation
October 9, 2025 - - Latest News -
Officials outline ongoing measures to address ADHD medicine shortages
October 9, 2025 - - Latest News -
Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs
October 9, 2025 - - Latest News -
Australian company reports positive outcome from collaboration
October 8, 2025 - - Australian Biotech -
CUREator opens $33 million funding round with CSL and AbbVie partnership
October 8, 2025 - - Latest News